Page 104 - AN-3-1

Advanced Neurology Neurological adverse events post-vaccination

44. Ricke DO. VAERS-Tools; 2022. Available from: https:// papillomavirus vaccine: A cluster analysis of reports in
github.com/doricke/vaers-tools [Last accessed on 2023 Dec VigiBase®. Drug Saf. 2017;40(1):81-90.
28].
doi: 10.1007/s40264-016-0456-3
45. Sutherland A, Izurieta HS, Ball R, et al. Syncope after
vaccination--United States, January 2005-July 2007. MMWR 53. Stefanizzi P, Bianchi FP, Spinelli G, et al. Postmarketing
Morb Mortal Wkly Rep. 2008;57(17):457-460. surveillance of adverse events following meningococcal B
vaccination: Data from Apulia region, 2014-19. Hum Vaccin
46. Geier DA, Geier MR. An evaluation of serious neurological Immunother. 2022;18(1):1-6.
disorders following immunization: A comparison of whole-
cell pertussis and acellular pertussis vaccines. Brain Dev. doi: 10.1080/21645515.2021.1963171
2004;26(5):296-300. 54. Shafiq A, Salameh MA, Laswi I, et al. Neurological immune-
doi: 10.1016/S0387-7604(03)00169-4 related adverse events after COVID-19 vaccination:
A systematic review. J Clin Pharmacol. 2022;62(3):291-303.
47. CDC. Child and Adolescent Immunization Schedule by
Age; 2023. Available from: https://www.cdc.gov/vaccines/ doi: 10.1002/jcph.2017
schedules/hcp/imz/child-adolescent.html [Last accessed on 55. Frontera JA, Tamborska AA, Doheim MF, et al. Neurological
2023 Nov 01]. events reported after COVID-19 vaccines: An analysis of
48. Wan EYF, Ng VWS, Chang RSK, et al. Association between the VAERS. Ann Neurol. 2022;91(6):756-771.
risk of seizure and COVID-19 vaccinations: A self-controlled doi: 10.1002/ana.26339
case-series study. Epilepsia. 2022;63(12):3100-3110.
56. Harris DA, Hayes KN, Zullo AR, et al. Comparative risks
doi: 10.1111/epi.17436 of potential adverse events following COVID-19 mRNA
49. Roman-Urrestarazu A, Yang JC, van Kessel R, et al. Autism vaccination among older US adults. JAMA Netw Open.
incidence and spatial analysis in more than 7 million pupils in 2023;6(8):e2326852.
English schools: A retrospective, longitudinal, school registry doi: 10.1001/jamanetworkopen.2023.26852
study. Lancet Child Adolesc Health. 2022;6(12):857-868.
57. Ahmed SH, Waseem S, Shaikh TG, et al. SARS-CoV-2
doi: 10.1016/S2352-4642(22)00247-4 vaccine-associated-tinnitus: A review. Ann Med Surg (Lond).
50. NIMH. Autism Spectrum Disorder (ASD); 2024. Available 2022;75:103293.
from: https://www.nimh.nih.gov/health/statistics/autism- doi: 10.1016/j.amsu.2022.103293
spectrum-disorder-asd [Last accessed on 2024 Jan 12].
58. Eslait-Olaciregui S, Llinás-Caballero K, Patiño-Manjarrés D,
51. Geier MR, Stanbro H, Merril CR. Endotoxins in commercial Urbina-Ariza T, Cediel-Becerra JF, Domínguez-
vaccines. Appl Environ Microbiol. 1978;36(3):445-449. Domínguez CA. Serious neurological adverse events
doi: 10.1128/aem.36.3.445-449.1978 following immunization against SARS-CoV-2: A narrative
review of the literature. Ther Adv Drug Saf. 2023;14.
52. Chandler RE, Juhlin K, Fransson J, Caster O, Edwards IR,
Norén GN. Current safety concerns with human doi: 10.1177/20420986231165674

Volume 3 Issue 1 (2024) 11 https://doi.org/10.36922/an.2258